PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Growth Rank: 8 (As of Sep. 08, 2026) — 100% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PRAY PT Famon Awal Bros Sedaya Tbk ISX:PRAY
89 GF Score
Price Rp750.00
GF Value Rp904.34
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is PT Famon Awal Bros Sedaya Tbk Growth Rank?

PT Famon Awal Bros Sedaya Tbk ISX:PRAY +0.67% 89 Growth Rank is 8 as of Sep. 08, 2026, which is 100% above its 10-year median of 4.00. GuruFocus rates ISX:PRAY with a GF Score™ of 89/100 and a GF Value™ of Rp904.34 (Modestly Undervalued). The stock has 6 warning signs investors should review.

PT Famon Awal Bros Sedaya Tbk has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


PT Famon Awal Bros Sedaya Tbk Growth Rank Related Terms


ISX:PRAY vs HCA, THC, EHC: Growth Rank Comparison

For the Medical Care Facilities subindustry, PT Famon Awal Bros Sedaya Tbk's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Famon Awal Bros Sedaya Tbk Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Famon Awal Bros Sedaya Tbk's Growth Rank distribution charts can be found below:

* The bar in red indicates where PT Famon Awal Bros Sedaya Tbk's Growth Rank falls into.


ISX:PRAY
89GF Score
PT Famon Awal Bros Sedaya Tbk ISX:PRAY
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) has a Growth Rank of 8 as of Sep. 08, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on PT Famon Awal Bros Sedaya Tbk and its competitors. This is 100% above median its historical median of 4.00. Over the past decade, PT Famon Awal Bros Sedaya Tbk's Growth Rank has ranged from 4.00 to 8.00.
Is PT Famon Awal Bros Sedaya Tbk's Growth Rank too high?
PT Famon Awal Bros Sedaya Tbk's current Growth Rank of 8 is 100% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. Overall, PT Famon Awal Bros Sedaya Tbk has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Famon Awal Bros Sedaya Tbk's Growth Rank compare to HCA and THC?
PT Famon Awal Bros Sedaya Tbk's Growth Rank of 8 can be compared against companies in the Healthcare Providers & Services industry. Historically, PT Famon Awal Bros Sedaya Tbk's own Growth Rank has ranged from 4.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on PT Famon Awal Bros Sedaya Tbk and its competitors. PT Famon Awal Bros Sedaya Tbk's current Growth Rank is 8, which is 100% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Famon Awal Bros Sedaya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp904.34, compared to a current price of Rp750.00 — trading 17.1% below its estimated fair value. The current Growth Rank is 8, which is 100% above median its 10-year median of 4.00. PT Famon Awal Bros Sedaya Tbk's overall GF Score™ is 89/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For PT Famon Awal Bros Sedaya Tbk (ISX:PRAY), the current Growth Rank is 8 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Overvalued in 2026?

Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk stock appears to be undervalued. The current stock price of Rp750.00 is trading 17.1% below its estimated GF Value™ of Rp904.34. GuruFocus considers PT Famon Awal Bros Sedaya Tbk to be Modestly Undervalued.

Key valuation signals for ISX:PRAY:

  • Growth Rank: 8 (100% above median its 10-year median of 4.00)
  • GF Value™: Rp904.34 vs. price of Rp750.00 (17.1% below fair value)
  • GF Score™: 89/100 with 6 warning signs

No single metric tells the full story. See the ISX:PRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Famon Awal Bros Sedaya Tbk Business Description

Address Ruko Mega Grosir Cempaka Mas Blok N/21, Kel. Sumur Batu, Kec. Kemayoran, Jakarta Pusat, Jakarta, IDN, 10640
PT Famon Awal Bros Sedaya Tbk operates as a hospital. The company7 provides comprehensive health services for Indonesians and foreign nationals (foreigners) and provides patient services with guarantees from companies, insurance, BPJS, and personal payments. Its hospital network has spread across different cities in Indonesia, including Jakarta, Bekasi, Tangerang, Semarang, Sukabumi, Makassar, Palangkaraya, and Pangkal Pinang. The services that it provides for patients include heart and blood vessel service centers, mother and child services, sports clinic & orthopedic services, cancer services, eye care centers & urology centers. The company's segments are Java; Kalimantan dan/ and Sulawesi; and Sumatera. It derives maximum revenue from Jawa.
89GF Score

Get the complete analysis for ISX:PRAY

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp750.00
Price
Rp904.34
GF Value